Evogene to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference from January 25-27th, 2022
Evogene Ltd. (NASDAQ: EVGN) announced its participation in the Edison Group's Global Healthcare Open House Event from January 25-27, 2022. The event will take place virtually, and Evogene's presentation will be available on demand starting at 7 AM ET on January 27. Attendees can also register for 1x1 meetings with the company. Evogene utilizes its Computational Predictive Biology platform to advance product pipelines in various life-science sectors, including human health and agriculture.
- None.
- None.
REHOVOT, Israel, Jan. 19, 2022 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today it is participating in Edison Group's Open House Event, scheduled to take place virtually this month.
For more information on the event and details on how to register, please see below.
Edison Group:
Global Healthcare Open House Conference 2022
Date: January 25-27th, 2022
Event information
Presentation information: The company presentation will be available on demand on http://www.edisongroup.com beginning at 7am ET on Thursday, January 27th. A replay of the presentation will also be available on Evogene's investor relations page.
1x1 Meeting Registration: To register for a 1x1 meetings with Company, please visit this link.
For any questions about the event or how to register, please reach out to lyonker@edisongroup.com.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN) (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of our broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ag Ltd. For more information, please visit www.evogene.com.
About Edison Group:
Edison is an investment research, investor relations and consulting firm, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is its world-renowned equity research platform and deep multi-sector expertise. Edison investment research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages its core research platform to provide differentiated services including investor relations and strategic consulting.
Contact:
Rivka Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1940
US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030
Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035
View original content:https://www.prnewswire.com/news-releases/evogene-to-participate-in-edison-groups-global-healthcare-open-house-virtual-conference-from-january-25-27th-2022-301463616.html
SOURCE Evogene
FAQ
What is the date of the Edison Group's Open House Event for Evogene?
Where can I find Evogene's presentation during the conference?
How can I register for 1x1 meetings with Evogene?
What is the focus of Evogene's Computational Predictive Biology platform?
What industries does Evogene target with its products?
